Antibiotic-resistant bacteria originating from the gut may modulate the mucosal immune response during sepsis and septic shock.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 81, doi. 10.33393/dti.2022.2520
- By:
- Publication type:
- Article
Works matching IS 11773928 AND DT 2022 AND VI 16 AND IP 1
Results: 12
1
2
Antimicrobial resistance surveillance system mapping in different countries.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 36, doi. 10.33393/dti.2022.2482
- By:
- Publication type:
- Article
3
MRSA carriage among healthcare workers in a Vietnamese intensive care unit: a prospective cohort study.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 71, doi. 10.33393/dti.2022.2504
- By:
- Publication type:
- Article
4
AMR research: a perspective from personal experience.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 69, doi. 10.33393/dti.2022.2545
- By:
- Publication type:
- Article
5
Exploring the inhibitory mechanisms of indazole compounds against SAH/MTAN-mediated quorum sensing utilizing QSAR and docking.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 54, doi. 10.33393/dti.2022.2512
- By:
- Publication type:
- Article
6
Success of 14-day triple and quadruple therapy for the control of Helicobacter pylori infections in Kohat district.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 49, doi. 10.33393/dti.2022.2481
- By:
- Publication type:
- Article
7
Unmet needs for management of drug-resistant infections: low- and middle-income countries' viewpoint.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 78, doi. 10.33393/dti.2022.2532
- By:
- Publication type:
- Article
8
Understanding the environmental drivers of clinical azole resistance in Aspergillus species.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 25, doi. 10.33393/dti.2022.2476
- By:
- Publication type:
- Article
9
Redefining genomic view of Clostridioides difficile through pangenome analysis and identification of drug targets from its core genome.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 17, doi. 10.33393/dti.2022.2469
- By:
- Publication type:
- Article
10
The association of ESBL Escherichia coli with mortality in patients with Escherichia coli bacteremia at the emergency department.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 12, doi. 10.33393/dti.2022.2422
- By:
- Publication type:
- Article
11
Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series.
- Published in:
- Drug Target Insights, 2022, v. 16, n. 1, p. 6, doi. 10.33393/dti.2022.2343
- By:
- Publication type:
- Article
12
Erythrodermic psoriasis and palmoplantar hyperkeratosis successfully treated with secukinumab: a case report.
- Published in:
- 2022
- By:
- Publication type:
- Case Study